Actively Recruiting
99Tc-MDP Treatment for Knee Osteoarthritis
Led by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Updated on 2026-04-28
40
Participants Needed
1
Research Sites
538 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Osteoarthritis (OA) of knee is the most common form of arthritis in the world1e, and it has received growing attention in the society because of the increase of old age population, disabled people, and medical expenses from this disease. 99Tc-MDP is effective for rheumatoid arthritis. Therefore, the investigators try to investigate the effects of 99Tc-MDP treatment in patients with osteoarthritis of knee as compared with celecoxib.
CONDITIONS
Official Title
99Tc-MDP Treatment for Knee Osteoarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants with painful osteoarthritis
- Standard uptake value of osteoarthritis-related knee greater than 10 on 18F-sodium fluoride bone scan
- Participants voluntarily participate and have signed informed consent
You will not qualify if you...
- Knee joint replacement
- Inflammatory arthritis or joint infection of knee
- Nervous joint disease
- Fracture of joint
- Gout arthritis of the knee
- Traumatic arthritis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Nuclear Medicine, Tenth People's Hospital of Tongji University
Shanghai, Shanghai Municipality, China, 200072
Actively Recruiting
Research Team
C
Chao Ma, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here